Probing GPCR structure: adenosine and P2Y nucleotide receptors

Area of Science:

• Structural biology
• Pharmacology
• Computational chemistry

Background:

• Adenosine receptors (ARs) are crucial drug targets, but their ligand recognition mechanisms were initially challenging to elucidate.
• Homology modeling has emerged as a powerful tool for understanding GPCR structures and interactions.
• Recent crystallographic data has significantly advanced knowledge of AR ligand binding and activation.

Purpose of the Study:

• To demonstrate the utility of homology modeling in predicting ligand recognition for ARs and related G protein-coupled receptors (GPCRs).
• To extend structural insights from ARs to other GPCRs, including P2Y receptors, for novel ligand design.
• To validate computational predictions through experimental methods like site-directed mutagenesis and neoceptor studies.

Main Methods:

• Homology modeling based on known GPCR structures (e.g., CXCR4).
• Site-directed mutagenesis to probe receptor-ligand interactions.
• Analysis of structure-activity relationships for small molecular ligands.
• X-ray crystallography to obtain high-resolution structural data.
• Neoceptor studies to create molecular complementarity between mutant receptors and tailored ligands.

Main Results:

• Homology modeling successfully predicted ligand recognition for ARs even before crystallographic structures were available.
• Recent X-ray structures confirmed and refined the understanding of AR ligand recognition and conformational changes.
• The homology modeling strategy is being successfully applied to P2Y receptors, which currently lack X-ray structures.
• Neoceptor studies validated docking hypotheses by demonstrating selective affinity enhancement through engineered molecular complementarity.

Conclusions:

• Homology modeling is a valuable strategy for predicting ligand recognition and guiding drug design for ARs and related GPCRs.
• Integrating computational modeling with experimental techniques provides deep structural insights into receptor function.
• This approach facilitates the discovery of novel ligands and therapeutic interventions for nucleotide receptor systems.